Atrial remodeling and the substrate for atrial fibrillation in rat hearts with elevated afterload

Circulation: Arrhythmia and Electrophysiology

Volumn 4, Issue 5, 2011, Pages 761-769

  Kim, Shang Jin ^a,b   Choisy, Stéphanie C M ^a   Barman, Palash ^a   Zhang, Haifei ^b   Hancox, Jules C ^b   Jones, Sandra A ^c   James, Andrew F ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b Chonbuk National University   (South Korea)

^c UNIVERSITY OF HULL   (United Kingdom)

Author keywords

Arrhythmia; Conduction; Connexin43; Fibrosis; Gap junctions

Indexed keywords

CONNEXIN 43; GAP JUNCTION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA STENOSIS; ARTICLE; ASCENDING AORTA; CONTROLLED STUDY; ELECTROGRAPHY; EPICARDIUM; HEART AFTERLOAD; HEART ARRHYTHMIA; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART ATRIUM HYPERTROPHY; HEART CONDUCTION; HEART LEFT ATRIUM; HEART MUSCLE FIBROSIS; HEART PACING; HEART PERFUSION; HISTOLOGY; IMMUNOCYTOCHEMISTRY; INCIDENCE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REFRACTORY PERIOD; ANIMAL; AORTA VALVE STENOSIS; CELL JUNCTION; DISEASE MODEL; FIBROSIS; HEART FUNCTION TEST; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CONDUCTION SYSTEM; HYPERTROPHY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; WISTAR RAT;

ANIMALS; AORTIC VALVE STENOSIS; ATRIAL FIBRILLATION; CONNEXIN 43; DISEASE MODELS, ANIMAL; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FIBROSIS; GAP JUNCTIONS; HEART ATRIA; HEART CONDUCTION SYSTEM; HYPERTROPHY; HYPERTROPHY, LEFT VENTRICULAR; MALE; RATS; RATS, WISTAR;

EID: 84555205726     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.111.964783     Document Type: Article

References (32)

1. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946-952. (Pubitemid 28446646)
2. Benjamin EJ, Chen P-S, Bild DE, Mascette AM, Albert CM, Alonso A, Calkins H, Connolly SJ, Curtis AB, Darbar D, Ellinor PT, Go AS, Goldschlager NF, Heckbert SR, Jalife J, Kerr CR, Levy D, Lloyd-Jones DM, Massie BM, Nattel S, Olgin JE, Packer DL, Po SS, Tsang TSM, Van Wagoner DR, Waldo AL, Wyse DG. Prevention of atrial fibrillation: report from a National Heart, Lung, and Blood Institute workshop. Circulation. 2009;119:606-618.
3. Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation. 1994;89:724-730. (Pubitemid 24056200)
4. Kerr CR, Humphries KH, Talajic M, Klein GJ, Connolly SJ, Green M, Boone J, Sheldon R, Dorian P, Newman D. Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation. Am Heart J. 2005;149:489-496. (Pubitemid 40585413)
5. Turhan H, Yetkin E, Atak R, Altinok T, Senen K, Ileri M, Sasmaz H, Cehreli S, Kutuk E. Increased P-wave duration and P-wave dispersion in patients with aortic stenosis. Ann Noninvasive Electrocardiol. 2003;8: 18-21. (Pubitemid 38569948)
6. Casaclang-Verzosa G, Gersh BJ, Tsang TSM. Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. J Am Coll Cardiol. 2008;51:1-11.
7. Tsang TSM, Gersh BJ, Appleton CP, Tajik AJ, Barnes ME, Bailey KR, Oh JK, Leibson C, Montgomery SC, Seward JB. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol. 2002;40: 1636-1644. (Pubitemid 35253642)
8. Tsang TSM, Barnes ME, Gersh BJ, Bailey KR, Seward JB. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol. 2002;90:1284-1289. (Pubitemid 35449471)
9. Vaziri SM, Larson MG, Lauer MS, Benjamin EJ, Levy D. Influence of blood pressure on left atrial size: the Framingham Heart Study. Hypertension. 1995;25:1155-1160.
10. Li D, Fareh S, Leung TK, Nattel S. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation. 1999;100:87-95. (Pubitemid 29297945)
11. Verheule S, Wilson E, Banthia S, Everett TH IV, Shanbhag S, Sih HJ, Olgin J. Direction-dependent conduction abnormalities in a canine model of atrial fibrillation due to chronic atrial dilatation. Am J Physiol. 2004; 287:H634-H644. (Pubitemid 38955294)
12. Verheule S, Wilson E, Everett T IV, Shanbhag S, Golden C, Olgin J. Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial dilatation due to mitral regurgitation. Circulation. 2003;107:2615-2622. (Pubitemid 36628945)
13. Choisy SCM, Arberry LA, Hancox JC, James AF. Increased susceptibility to atrial tachyarrhythmia in spontaneously hypertensive rat hearts. Hypertension. 2007;49:498-505.
14. Kistler PM, Sanders P, Dodic M, Spence SJ, Samuel CS, Zhao C, Charles JA, Edwards GA, Kalman JM. Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure: implications for development of atrial fibrillation. Eur Heart J. 2006;27:3045-3056. (Pubitemid 44950450)
15. Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein CS, Lorell BH. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation. J Clin Invest. 1990;86: 1913-1920.
16. Weinberg E, Schoen F, George D, Kagaya Y, Douglas P, Litwin S, Schunkert H, Benedict C, Lorell B. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation. 1994;90:1410-1422. (Pubitemid 24284463)
17. Lammers WJ, Schalij MJ, Kirchhof CJ, Allessie MA. Quantification of spatial inhomogeneity in conduction and initiation of reentrant atrial arrhythmias. Am J Physiol. 1990;259:H1254-H1263. (Pubitemid 20352329)
18. Verheule S, Sato T, Everett T IV, Engle SK, Otten D, Rubart-von der Lohe M, Nakajima HO, Nakajima H, Field LJ, Olgin JE. Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1. Circ Res. 2004;94: 1458-1465. (Pubitemid 38780318)
19. Allessie MA, Lammers WJ, Bonke IM, Hollen J. Intra-atrial reentry as a mechanism for atrial flutter induced by acetylcholine and rapid pacing in the dog. Circulation. 1984;70:123-135. (Pubitemid 14084073)
20. Jones SA, Lancaster MK, Boyett MR. Ageing-related changes of connexins and conduction within the sinoatrial node. J Physiol (Lond). 2004;560:429-437. (Pubitemid 39440105)
21. Feldman A, Weinberg E, Ray P, Lorell B. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res. 1993;73:184-192. (Pubitemid 23173069)
22. Spach MS, Boineau JP. Microfibrosis produces electrical load variations due to loss of side-to-side cell connections: a major mechanism of structural heart disease arrhythmias. Pacing Clin Electrophysiol. 1997; 20:397-413.
23. Severs NJ, Bruce AF, Dupont E, Rothery S. Remodelling of gap junctions and connexin expression in diseased myocardium. Cardiovasc Res. 2008; 80:9-19.
24. Nattel S. New ideas about atrial fibrillation 50 years on. Nature. 2002; 415:219-226. (Pubitemid 34059528)
25. Hayashi H, Wang C, Miyauchi Y, Omichi C, Pak HN, Zhou S, Ohara T, Mandel WJ, Lin SF, Fishbein MC, Chen PS, Karagueuzian HS. Agingrelated increase to inducible atrial fibrillation in the rat model. J Cardiovasc Electrophysiol. 2002;13:801-808. (Pubitemid 34921142)
26. Adam O, Lavall D, Theobald K, Hohl M, Grube M, Ameling S, Sussman MA, Rosenkranz S, Kroemer HK, Schäfers H-J, Böhm M, Laufs U. Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation. J Am Coll Cardiol. 2010;55: 469-480.
27. Luo MH, Li YS, Yang KP. Fibrosis of collagen I and remodeling of connexin 43 in atrial myocardium of patients with atrial fibrillation. Cardiology. 2007;107:248-253. (Pubitemid 46788240)
28. Rucker-Martin C, Milliez P, Tan S, Decrouy X, Recouvreur M, Vranckx R, Delcayre C, Renaud J-F, Dunia I, Segretain D, Hatem SN. Chronic hemodynamic overload of the atria is an important factor for gap junction remodeling in human and rat hearts. Cardiovasc Res. 2006;72:69-79. (Pubitemid 44310634)
29. Kostin S, Klein G, Szalay Z, Hein S, Bauer EP, Schaper J. Structural correlate of atrial fibrillation in human patients. Cardiovasc Res. 2002; 54:361-379. (Pubitemid 34327915)
30. Polontchouk L, Haefliger J-A, Ebelt B, Schaefer T, Stuhlmann D, Mehlhorn U, Kuhn-Regnier F, De Vivie ER, Dhein S. Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria. J Am Coll Cardiol. 2001;38:883-891. (Pubitemid 32835768)
31. Burstein B, Comtois P, Michael G, Nishida K, Villeneuve L, Yeh Y-H, Nattel S. Changes in connexin expression and the atrial fibrillation substrate in congestive heart failure. Circ Res. 2009;105:1213-1222.
32. Laurent G, Leong-Poi H, Mangat I, Moe GW, Hu X, So PP-S, Tarulli E, Ramadeen A, Rossman EI, Hennan JK, Dorian P. Effects of chronic gap junction conduction-enhancing antiarrhythmic peptide GAP-134 administration on experimental atrial fibrillation in dogs. Circ Arrhythm Electrophysiol. 2009;2:171-178.